期刊文献+

The role of mouse models in colorectal cancer research—The need and the importance of the orthotopic models 被引量:8

暂未订购
导出
摘要 Colorectal cancer is a worldwide health burden,with high incidence and mortality,especially in the advanced stages of the disease.Preclinical models are very important and valuable to discover and validate early and specific biomarkers as well as new therapeutic targets.In order to accomplish that,the animal models must replicate the clinical evolution of the disease in all of its phases.In this article,we review the existent mouse models,with their strengths and weaknesses in the replication of human cancer disease progression,with major focus on orthotopic models.
出处 《Animal Models and Experimental Medicine》 CSCD 2020年第1期1-8,共8页 动物模型与实验医学(英文)
  • 相关文献

参考文献2

二级参考文献39

  • 1Andreas Stang,Roland Stabenow,Christa Stegmaier,Bettina Eisinger,Edeltraud Bischof-Hammes,Karl-Heinz J?ckel.Unexplained inversion of the incidence ratio of colon and rectal cancer among men in East Germany. A time trend analysis including 147,790 cases[J].European Journal of Epidemiology.2007(4)
  • 2V. N. Papadopoulos,A. Michalopoulos,S. Netta,G. Basdanis,D. Paramythiotis,A. Zatagias,P. Berovalis,N. Harlaftis.Prognostic significance of mucinous component in colorectal carcinoma[J].Techniques in Coloproctology.2004(1)
  • 3V. Bazan,M. Migliavacca,I. Zanna,C. Tubiolo,S. Corsale,V. Calò,A. Amato,P. Cammareri,F. Latteri,N. Grassi,F. Fulfaro,R. Porcasi,V. Morello,R. Nuara,G. Dardanoni,S. Salerno,M. Valerio,L. Dusonchet,A. Gerbino,N. Gebbia,R. Tomasino,A. Russo.DNA Ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective study[J].Journal of Cancer Research and Clinical Oncology.2002(12)
  • 4Pascal Gervaz M.D.,Hanifa Bouzourene M.D.,Jean-Philippe Cerottini M.D.,Pascal Chaubert M.D.,Jean Benhattar Ph.D,Michelle Secic M.S.,Dr. Steven Wexner M.D.,Jean-Claude Givel M.D.,Bruce Belin M.D.Dukes B colorectal cancer[J].Diseases of the Colon & Rectum.2001(3)
  • 5Sergio Casillas M.D.,Robert J. Pelley M.D.,Jeffrey W. Milsom M.D.Adjuvant therapy for colorectal cancer[J].Diseases of the Colon & Rectum.1997(8)
  • 6Dr. S. E. Patchett M.D.,E. M. Alstead M.D.,B. P. Saunders M.R.C.P.,S. V. Hodgson M.D.,M. J. G. Farthing M.D.Regional proliferative patterns in the colon of patients at risk for hereditary nonpolyposis colorectal cancer[J].Diseases of the Colon & Rectum.1997(2)
  • 7S. Crerand,T. M. Feeley,R. P. Waldron,T. Corrigan,W. Hederman,F. X. O’Connell,S. J. Heffernan.Colorectal carcinoma over 30 years at one hospital: no evidence for a shift to the right[J].International Journal of Colorectal Disease.1991(4)
  • 8Jeremy R. Jass B.Sc. M.D.Subsite distribution and incidence of colorectal cancer in New Zealand, 1974–1983[J].Diseases of the Colon & Rectum.1991(1)
  • 9Robert W. Beart M.D.,L. Joseph Melton M.D.,Morito Maruta M.D.,Malcolm B. Dockerty M.D.,Harry B. Frydenberg M.D.,W. Michael O’Fallon Ph.D.Trends in right and left-sided colon cancer[J].Diseases of the Colon & Rectum.1983(6)
  • 10AHCPR (Agency for Health Care Policy and Research).Colorectal Cancer Screening. AHCPR Publication No. 98-0033 . 1998

共引文献14

同被引文献55

引证文献8

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部